Today the Drug Enforcement Administration will visit Dr. John Halpern of Harvard Medical School’s McLean Hospital as a routine procedure before issuing his Schedule I license. Once Dr. Halpern has received his license, the MAPS-funded study of MDMA-assisted psychotherapy for anxiety in advanced cancer patients can begin.
